The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PRE | +193.69% | N/A | N/A | -88% |
| S&P | +19.61% | +98.99% | +14.75% | +58% |
Prenetics Global Ltd. engages in the provision of preventive and diagnostic health testing and services. It operates through the following segments: Prevention, Diagnostics, and Personalized Care. The Prevention segment delivers genetic testing services to individuals and corporate entities. The Diagnostics segment includes COVID-19 testing services for individuals, corporate clients, and governments for community testing. The Personalized Care segment offers personalized nutrition, hair loss, and sexual health products tailored to each of customer's individual and genetic variation and biology. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $14.96M | 151.9% |
| Gross Profit | $5.84M | 187.6% |
| Gross Margin | 38.99% | 4.8% |
| Market Cap | $110.98M | 53.4% |
| Market Cap / Employee | $0.39M | 0.0% |
| Employees | 285 | -12.0% |
| Net Income | -$8.76M | 22.0% |
| EBITDA | -$5.93M | 24.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $17.25M | -58.1% |
| Accounts Receivable | $1.85M | -54.8% |
| Inventory | 4.3 | 49.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.05M | -11.3% |
| Short Term Debt | $1.53M | 29.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -21.19% | -1.9% |
| Return On Invested Capital | -85.42% | 19.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.24 | 0.40 | 0.27 | 0.64 | 76.28% |
| Price to Sales | 1.99 | 2.40 | 1.23 | 2.03 | -36.31% |
| Price to Tangible Book Value | 0.31 | 0.55 | 0.37 | 0.92 | 99.11% |
| Enterprise Value to EBITDA | -2.03 | -2.11 | 0.22 | -13.09 | 322.32% |
| Return on Equity | -23.8% | -24.6% | -26.7% | -27.0% | 9.93% |
| Total Debt | $6.49M | $5.77M | $5.15M | $2.57M | 8.86% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
